Co-Founder & Chief Scientific Officer
Janine Sengstack is co-Founder and chief scientific officer of Junevity, a longevity biotech developing Cell Reset therapeutics. Junevity’s RESET platform is the first to identify transcription factor targets for siRNA repression based on large-scale human data and AI. Janine earned her Ph.D. from UC San Francisco in 2023 in cellular aging, where she invented the core technology for Junevity.